Optinose to Present at the Jefferies Virtual Healthcare Conference

YARDLEY, Pa., June 01, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 3:30 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor ContactJonathan Neely[email protected] 267.521.0531

You May Also Be Interested In

• Par Pacific Holdings Reports Second Quarter 2026 Results
• Riot Reschedules Second Quarter 2026 Earnings Conference Call
• SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility